search
Aumseqa
Trends
- 1Hansoh to refile Aumseqa in EU after approval revoked●Hansoh plans new EU filing after Aumseqa approval revoked
Chinese drugmaker Hansoh Pharmaceutical says it plans to submit a new marketing application to the European Medicines Agency after the EU approval of Aumseqa was revoked. The company is seeking to regain a foothold in the European market for the medicine, though details of the refiled application and its chances of success have not been disclosed.